학술논문

Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.
Document Type
journal article
Source
Journal of Clinical Oncology; 10/1/2017, Vol. 35 Issue 28, p3189-3197, 22p
Subject
Language
ISSN
0732183X